These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 8061340

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Serum soluble interleukin-2 receptor (sIL-2R) assay in cervical and endometrial cancer. Preliminary data.
    Ferdeghini M, Gadducci A, Prontera C, Marrai R, Malagnino G, Annicchiarico C, Fioretti P, Bianchi R.
    Anticancer Res; 1993; 13(3):709-13. PubMed ID: 8317901
    [Abstract] [Full Text] [Related]

  • 23. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites.
    Elg SA, Hill RB, Heldman L, Ramakrishnan S.
    Gynecol Oncol; 1997 Jul; 66(1):133-7. PubMed ID: 9234933
    [Abstract] [Full Text] [Related]

  • 24. [Soluble interleukin 2 receptor (sIL-2R) in patients with esophageal carcinoma].
    Duan ZF.
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):17-9. PubMed ID: 8334935
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
    Shimomura Y, Tsurumi H, Sawada M, Yamada T, Hara T, Fukuno K, Goto H, Moriwaki H.
    Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
    [Abstract] [Full Text] [Related]

  • 28. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D.
    Roum Arch Microbiol Immunol; 2001 Aug; 60(3):183-201. PubMed ID: 12165973
    [Abstract] [Full Text] [Related]

  • 29. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
    Oka M, Hazama S, Takahashi M, Yamamoto K, Abe T, Yoshino S, Hayashi H, Tangoku A.
    Hepatogastroenterology; 1999 Aug; 46(28):2254-9. PubMed ID: 10521976
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Anti asialoglycoprotein receptor antibodies and soluble interleukin-2 receptor levels as marker for inflammation in autoimmune hepatitis.
    Dejica D, Treichel U, Pár A, Chira O, Meyer zum Büschenfelde KH.
    Z Gastroenterol; 1997 Jan; 35(1):15-21. PubMed ID: 9123953
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. C reactive protein in pancreatic cancer and chronic pancreatitis.
    Basso D, Fabris C, Meani A, Del Favero G, Vianello D, Angonese C, Meggiato T, Bellinvia S, Fogar P, Petrin P.
    Ann Clin Res; 1988 Jan; 20(6):414-6. PubMed ID: 3218913
    [Abstract] [Full Text] [Related]

  • 35. Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis.
    Pezzilli R, Billi P, Gullo L, Beltrandi E, Maldini M, Mancini R, Incorvaia L, Miglioli M.
    Digestion; 1994 Jan; 55(4):268-73. PubMed ID: 8063032
    [Abstract] [Full Text] [Related]

  • 36. The soluble interleukin-2 receptor as a marker for human neoplasia and immune status.
    Zerler B.
    Cancer Cells; 1991 Dec; 3(12):471-9. PubMed ID: 1820093
    [Abstract] [Full Text] [Related]

  • 37. Comparison of a new immunoassay for determining serum pancreatic isoamylase with two standard techniques.
    Ventrucci M, Pezzilli R, Gullo L.
    Am J Gastroenterol; 1990 Oct; 85(10):1381-5. PubMed ID: 2220732
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Clinical significance of increased serum soluble interleukin-2 receptor levels in patients with pulmonary tuberculosis].
    Chui JJ, Fan P, Li J.
    Zhonghua Jie He He Hu Xi Za Zhi; 1994 Oct; 17(5):288-90, 318-9. PubMed ID: 7712570
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.